SciMed Solutions Releases Scalable Adjuvant Discovery Software

DURHAM, N.C., April 9, 2020 /PRNewswire/ — SciMed Solutions today announced the release of Compound Scout, a high-throughput adjuvant screening software initially developed for use by the Duke Human Vaccine Institute (DHVI). Compound Scout is now available for use by small to mid-sized labs and primary researchers in a scalable software as a service (SaaS) model.

“We continually face novel and mutating viruses and bacteria that require the development of new vaccines and pharmaceuticals,” says Adam Stasio, president of SciMed Solutions. “Storing, managing, and analyzing high-throughput screening data efficiently and effectively has been out of reach for many primary researchers and smaller, independent labs. We are offering Compound Scout in a scalable SaaS version that makes it affordable for researchers, enabling them to accurately increase their testing speed and help new vaccines and medications get to market more quickly.” Compound Scout was developed to increase testing capacity for adjuvant and drug screening, biopharmaceutical development, and vaccine research.

About SciMed Solutions

SciMed Solutions builds innovative software products and provides consulting services to streamline workflows and increase efficiency so researchers can focus on your core mission. Located in downtown Durham, North Carolina, SciMed has been developing software since 2003. Learn more about SciMed Solutions at www.scimedsolutions.com or visit the Compound Scout website at www.compoundscout.com.

 

View original content:http://www.prnewswire.com/news-releases/scimed-solutions-releases-scalable-adjuvant-discovery-software-301038493.html

SOURCE SciMed Solutions

Staff

Recent Posts

MindHYVE.ai™ and KPSIAJ Sign Strategic MOU to Advance AI-Driven Innovation in Education and Healthcare Across Karachi

KARACHI, Pakistan, Dec. 22, 2025 /PRNewswire/ -- MindHYVE.ai, Inc., and Khoja (Pirhai) Shia Isna Asheri Jamaat…

1 hour ago

Castle Connolly Names Dr. Meegan Gruber, MD, PhD a 2026 Exceptional Woman in Medicine; Recognition to Be Featured in New York Magazine

Board-certified plastic surgeon and surgeon-scientist honored for clinical excellence, leadership, and commitment to patient education. …

1 hour ago

Planning Time Off in 2026: Dr. Meegan Gruber, MD, PhD Releases a Recovery-Logistics Guide for Busy Professionals Considering Plastic Surgery

New "Recovery Logistics" checklist helps patients coordinate work, childcare, travel, and follow-up support-before they choose…

1 hour ago

How to Choose a Plastic Surgeon in 2026: Dr. Meegan Gruber, MD, PhD Releases a Tampa Bay Patient Safety Checklist

Board-certified plastic surgeon shares a practical, question-based guide to help patients verify credentials, facility standards,…

1 hour ago

Facelift + Eyelid Surgery in Tampa: Gruber Plastic Surgery Shares 2025 Planning Insights on Natural Results and Popular Procedure Pairings

ASPS trend reporting highlights facelift combined with eyelid surgery as a leading 2025 combination; national…

1 hour ago

CV Sciences, Inc. Positioned to Participate in the Medicare and Medicaid Pilot Program for CBD

SAN DIEGO, CA / ACCESS Newswire / December 22, 2025 / CV Sciences, Inc. (OTCQB:CVSI)…

4 hours ago